期刊文献+

608株不动杆菌的来源分布及耐药特征分析

The Distribution and the Resistance Characteristics of 608 Strains of Acinetobacter
下载PDF
导出
摘要 目的了解临床分离的不动杆菌对15种抗生素的耐药特征,为该类感染的药物选择提供依据。方法收集2007年11月。2009年11月临床标本中分离到的不动杆菌,用VITEK全自动微生物分析仪进行鉴定及药敏实验。结果608株不动杆菌中鲍曼不动杆菌538株,洛菲不动杆菌70株,药敏结果显示,鲍曼不动杆菌对亚胺培南最为敏感,耐药率27.1%;其次为头孢哌酮/舒巴坦,耐药率为27.9%。而洛菲不动杆菌对所有药物的耐药率均较低,多数在30%以下。结论不动杆菌是医院感染的重要病原菌,鲍曼不动杆菌耐药率最高,部分菌株呈多重耐药,临床抗感染治疗应根据药敏试验结果选用合适抗菌药物。 Objective To investigate the distribution and the resistance characteristics on 15 kinds of antibiotics of 608 strains of Acinetobacter clinical isolates in our hospital,to provide the basis for selection of anti-infectives.Methods From Nov.2007 to Nov.2009,in our hospital,isolated Acinetobacter from clinical specimens,with the VITEK Automated Microbiology Analyzer identification and susceptibility testing.Results In 608 Acinetobacter baumannii 538,70 strains ofAcinetobacter Lwoffi,drug susceptibility results showed that A.baumannii is most sensitive to imipenem,resistance was 27.1%;followed by cefoperazone/sulbactam,resistance rate was 27.9%.The Lwoffi Acinetobacter resistant to all drugs were low, most under 30%.Conclusions Acinetobacter is an important pathogen of nosoeomial infection,with high resistance rate of Acinetobacter baumannii.Some strains were multidrug resistant,clinical anti-infective therapy.Susceptibility testing should be based on the reslults of the appropriate choice of antimicrobial agents.
出处 《中国血液流变学杂志》 CAS 2012年第2期318-320,共3页 Chinese Journal of Hemorheology
关键词 不动杆菌 药敏试验 耐药特征 Acinetobacter susceptibility test resistance characteristics
  • 相关文献

参考文献4

二级参考文献15

  • 1王辉,刘颖梅,陈民钧,孙宏莉,谢秀丽,徐英春.鲍曼不动杆菌对碳青霉烯类耐药机制的研究[J].中国医学科学院学报,2003,25(5):567-572. 被引量:44
  • 2朱德妹,汪复,张婴元.2004年上海地区细菌耐药性监测[J].中国抗感染化疗杂志,2005,5(4):195-200. 被引量:227
  • 3汪复.应加强细菌耐药性和耐药菌感染的研究力度[J].中华医学杂志,2006,86(9):579-580. 被引量:34
  • 4朱德妹.进一步加强细菌耐药监测[J].中华检验医学杂志,2006,29(10):865-866. 被引量:34
  • 5朱士俊,新编实用医院感染学,1994年,351页
  • 6Jones RN,Pfaller MA.Bacterial resistance:a worldwide problem[J].Diagn Microbiol Infect Dis,1998,31:379-388.
  • 7World Health Organization.WHO global strategy for containment of antimierobial resistance[J].WHO/CDS/CSR/DRS/2001.2
  • 8Clinical and Laboratory Standads Institute.Performance Standards for Antimicrobial Susceptibility Testing[S].Fifteenth Informational Supplement,2005,M100-S15.
  • 9Hsueh PR,Teng LJ,Chen CY,et al.Pandrug-resistant acinetobacter baumannii causing nosoeomial infections in a university hospital,Taiwan[J].Emerg infect Dis,2002,8:827-832.
  • 10Clinical and Laboratory Standads Institute.Performance Standards for Antimicrobial Susceptibility Testing[s].Fifteenth Informational Supplement,2006,M100-S16.

共引文献284

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部